| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |